The global, regional, and national burden of benign prostatic hyperplasia in 204 countries and territories from 2000 to 2019.

The global, regional, and national burden of benign prostatic hyperplasia in 204 countries and territories from 2000 to 2019: a systematic analysis for the Global Burden of Disease Study 2019 – The Lancet Health Longevity

Invited Commentary: Benign prostatic hyperplasia: a global challenge of the ageing population – The Lancet Health Longevity